The Fox M1 in Human Glioma Development and Progression
The Fox M1 in Human Glioma Development and Progression
批准号:
7669213
负责人:
Suyun Huang
金额:
$21.23万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-09-15 至 2011-07-31
关键词:
AffectAnaplastic astrocytomaAnchorage-Independent GrowthAntibodiesAstrocytesAttenuatedBindingBinding SitesBiologyBoxingBrain NeoplasmsCell LineCell ProliferationCellsDataDevelopmentEngineeringFoxesGelatinase AGenesGeneticGenetic TranscriptionGlioblastomaGliomaGliomagenesisGoalsGrowthHumanIn VitroLeadMalignant GliomaMicroarray AnalysisModelingMolecularMolecular TargetMorbidity - disease rateMusNude MiceOligonucleotide MicroarraysPathway interactionsPhenotypePhosphotransferasesProliferatingProteinsProto-Oncogene Proteins c-aktRegulationResearchResearch PersonnelRoleSmall Interfering RNASystemTP53 geneTestingTransactivationTransfectionTransgenesTransgenic MiceTumor Cell InvasionVascular Endothelial Growth FactorsWorkangiogenesiscell transformationin vivoinsightmTOR proteinmalignant phenotypemortalitymouse modelneoplastic cellnew therapeutic targetoverexpressionprogramspromotertranscription factortransgene expressiontumor growth
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Malignant gliomas are the most common brain tumors and are associated with extremely high rates of morbidity and mortality. The long-term goal of our research is to reveal the molecular mechanisms underlying glioma development and progression, of which very little is currently known. Recent studies using oligonucleotide microarray analysis have shown that alteration to the Forkhead box M1 (FoxM1) transcription factor is one of the most frequent molecular alterations in malignant gliomas. Our preliminary results indicate a direct correlation between FoxM1 expression level and the grade of gliomas. Enforced FoxM1 expression in immortalized normal human astrocytes (NHAs) was sufficient to transform the cells into glioma cells. Enforced FoxM1 expression in anaplastic astrocytoma cells promoted their progression into glioblastomas in nude mouse models, and suppressed FoxM1 expression inhibited the anchorage-independent growth of glioblastoma cells. Moreover, gliomas arisen from FoxM1-transfected cells were highly proliferative, invasive, and angiogenic. FoxM1-transfected glioma cells had increased expression of activated Akt, VEGF and MMP-2, whereas FoxM1-siRNA-transfected glioma cells had decreased expression of activated Akt. Here, we propose to determine the causal effects and mechanisms of aberrant FoxM1 expression on glioma development and progression. We hypothesize that aberrant expression of FoxM1 contributes to glioma development and progression by promoting uncontrolled cell proliferation, invasion, and angiogenesis. Our Specific Aims are 1) To determine the effect of altered FoxM1 expression on glioma biology. We will determine the critical contribution of FoxM1 to glioma cell proliferation, invasion, and angiogenesis in vitro and in vivo by using the FoxM1-siRNA inhibition system, FoxM1-overexpressing cell lines, and in vivo mouse models. 2) To determine the cooperation between FoxM1 overexpression and Rb loss in glioma development and progression. We will investigate whether FoxM1 transgene expression accelerates glioma formation and promotes glioma progression in a genetic mouse glioma model with an inactivated pRb pathway. 3) To determine whether FoxM1 overexpression contributes to glioma development and progression via activation of Akt pathway. 4) To identify the molecular mechanisms by which FoxM1 regulates glioma invasion and angiogenesis. The mechanisms of FoxM1 regulating invasion and angiogenesis will be investigated with a particular focusing on how it regulates the expression of the MMP-2, and VEGF genes. The findings from our proposed studies will contribute to a better understanding of the molecular mechanisms of glioma development and progression and will identify potential targets for novel therapeutic strategies against malignant glioma.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1158/1078-0432.ccr-12-1588
发表时间:
2013-01-01
期刊:
Clinical cancer research : an official journal of the American Association for Cancer Research
影响因子:
--
作者:
[Li D, Wei P, Peng Z, Huang C, Tang H, Jia Z, Cui J, Le X, Huang S, Xie K]
通讯作者:
Xie K
DOI:
10.1158/1078-0432.ccr-14-2437
发表时间:
2015-02-15
期刊:
Clinical cancer research : an official journal of the American Association for Cancer Research
影响因子:
--
作者:
[Li Z, Jia Z, Gao Y, Xie D, Wei D, Cui J, Mishra L, Huang S, Zhang Y, Xie K]
通讯作者:
Xie K
DOI:
10.1158/0008-5472.can-10-4249
发表时间:
2011-07-15
期刊:
Cancer research
影响因子:
11.2
作者:
[Chiu WT, Lee HT, Huang FJ, Aldape KD, Yao J, Steeg PS, Chou CY, Lu Z, Xie K, Huang S]
通讯作者:
Huang S
FOXM1 promotes the warburg effect and pancreatic cancer progression via transactivation of LDHA expression.
FOXM1 通过 LDHA 表达的反式激活促进瓦尔堡效应和胰腺癌进展。
DOI:
10.1158/1078-0432.ccr-13-2407
发表时间:
2014-05-15
期刊:
Clinical cancer research : an official journal of the American Association for Cancer Research
影响因子:
--
作者:
[Cui J, Shi M, Xie D, Wei D, Jia Z, Zheng S, Gao Y, Huang S, Xie K]
通讯作者:
Xie K
DOI:
10.1158/0008-5472.can-11-3102
发表时间:
2012-02-01
期刊:
Cancer research
影响因子:
11.2
作者:
[Huang C, Qiu Z, Wang L, Peng Z, Jia Z, Logsdon CD, Le X, Wei D, Huang S, Xie K]
通讯作者:
Xie K
共 7 条
Epigenetic Modulation of Wnt/Beta-catenin Pathway and Tumorigenesis of Glioma Cells by KDM4C
-
批准号:9977964
-
项目类别:
-
资助金额:$35.51万
-
财政年份:2019
-
负责人:Suyun Huang
-
依托单位:
Interplay between ubiquitination and epigenetic regulation of EGFR signaling in gliomagenesis
-
批准号:10225383
-
项目类别:
-
资助金额:$33.96万
-
财政年份:2019
-
负责人:Suyun Huang
-
依托单位:
Epigenetic Modulation of Wnt/Beta-catenin Pathway and Tumorigenesis of Glioma Cells by KDM4C
-
批准号:9127615
-
项目类别:
-
资助金额:$36.6万
-
财政年份:2016
-
负责人:Suyun Huang
-
依托单位:
Signal Integration of Transcriptional Pathways in Gliomagenesis
-
批准号:8987549
-
项目类别:
-
资助金额:$33.57万
-
财政年份:2014
-
负责人:Suyun Huang
-
依托单位:
Signal Integration of Transcriptional Pathways in Gliomagenesis
-
批准号:8788396
-
项目类别:
-
资助金额:$33.55万
-
财政年份:2014
-
负责人:Suyun Huang
-
依托单位:
Signal Integration of Transcriptional Pathways in Gliomagenesis
-
批准号:9820664
-
项目类别:
-
资助金额:$28.78万
-
财政年份:2014
-
负责人:Suyun Huang
-
依托单位:
Signal Integration of Transcriptional Pathways in Gliomagenesis
-
批准号:8624856
-
项目类别:
-
资助金额:$35.03万
-
财政年份:2014
-
负责人:Suyun Huang
-
依托单位:
Transcriptional regulation of gliomagenesis
-
批准号:8296327
-
项目类别:
-
资助金额:$32.79万
-
财政年份:2011
-
负责人:Suyun Huang
-
依托单位:
Transcriptional regulation of gliomagenesis
-
批准号:8657903
-
项目类别:
-
资助金额:$31.8万
-
财政年份:2011
-
负责人:Suyun Huang
-
依托单位:
Transcriptional regulation of gliomagenesis
-
批准号:8186322
-
项目类别:
-
资助金额:$32.79万
-
财政年份:2011
-
负责人:Suyun Huang
-
依托单位:
Transcriptional regulation of gliomagenesis
-
批准号:8466883
-
项目类别:
-
资助金额:$30.82万
-
财政年份:2011
-
负责人:Suyun Huang
-
依托单位:
Novel Molecular Mechanism of Glioma Pathogenesis
-
批准号:7976424
-
项目类别:
-
资助金额:$20.62万
-
财政年份:2010
-
负责人:Suyun Huang
-
依托单位:
Novel Molecular Mechanism of Glioma Pathogenesis
-
批准号:8094270
-
项目类别:
-
资助金额:$16.67万
-
财政年份:2010
-
负责人:Suyun Huang
-
依托单位:
The Fox M1 in Human Glioma Development and Progression
-
批准号:7495043
-
项目类别:
-
资助金额:$21.23万
-
财政年份:2006
-
负责人:Suyun Huang
-
依托单位:
The Fox M1 in Human Glioma Development and Progression
-
批准号:7148378
-
项目类别:
-
资助金额:$21.87万
-
财政年份:2006
-
负责人:Suyun Huang
-
依托单位:
The Fox M1 in Human Glioma Development and Progression
-
批准号:7286288
-
项目类别:
-
资助金额:$21.23万
-
财政年份:2006
-
负责人:Suyun Huang
-
依托单位:
海外基金